Imodiumcaps (Loperamide Hydrochloride)

• Imodiumcaps acts on the gastrointestinal tract to reduce excessive bowel movements associated with several diarrheal conditions.
• Acute nonspecific diarrhea: provides symptomatic relief by slowing intestinal transit.
• Chronic diarrhea associated with inflammatory bowel disease: helps control stool frequency and consistency.
• Irritable bowel syndrome with diarrhea: reduces urgency and improves quality of life.

• Loperamide Hydrochloride binds to peripheral µ‑opioid receptors in the myenteric plexus of the intestine, inhibiting acetylcholine release and reducing smooth‑muscle activity. This decreases intestinal motility, prolongs transit time, and enhances water and electrolyte absorption, resulting in firmer stools and reduced frequency of bowel movements.

Loperamide Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Constipation: reduced bowel movements.
• Abdominal cramps: mild to moderate discomfort.
• Nausea: occasional feeling of queasiness.
• Dry mouth: reduced salivation.
• Dizziness: transient light‑headedness.
• Fatigue: mild tiredness.

Serious or Rare Side Effects

• Severe constipation leading to bowel obstruction.
• Paralytic ileus: loss of intestinal peristalsis.
• Cardiac arrhythmias: especially at high doses.
• Allergic reactions: rash, itching, swelling.
• Central nervous system effects: confusion, drowsiness.
• Toxic megacolon in patients with ulcerative colitis.

• Before using Imodiumcaps, consider the following safety measures.
• Do not exceed recommended dose: follow prescriber instructions to avoid toxicity.
• Avoid use in patients with known hypersensitivity: discontinue if allergic reaction occurs.
• Caution in hepatic impairment: liver disease may increase drug exposure.
• Monitor for signs of constipation: adjust therapy if stools become hard or infrequent.
• Avoid in children under two years: not indicated for this age group.
• Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Loperamide Hydrochloride can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase plasma levels.
• P-glycoprotein inhibitors (e.g., quinidine, ritonavir): raise systemic exposure.
• CNS depressants (e.g., opioids, benzodiazepines): enhance sedation risk.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: may worsen constipation.
• Antidiarrheal combinations: additive effect on motility.
• Antifungal azoles (e.g., fluconazole): modest increase in loperamide levels.